Your gut changes on GLP-1s — but you don’t have to feel miserable. These 23 probiotics smooth digestion, calm bloating, and ...
Recent studies show the surging popularity of Ozempic, Wegovy and similar drugs for weight loss is driving employer health ...
GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...
Novo Nordisk will soon announce the results of perhaps the most ambitious studies yet of its GLP-1 drug: whether it can help ...
GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long ...
Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...
Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...
This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...
Tirzepatide, semaglutide, and liraglutide lead to weight loss in adults with obesity and T1D over 1 year; the greatest weight ...
As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...
A GLP-1/glucagon dual agonist induced significant weight loss and improved multiple cardiometabolic parameters for adults ...
“In general, we tend to see more weight loss with GLP-1-based medication treatment in patients who are female, those who do ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results